Insider Selling: Encompass Health Co. (AMEX:EHC) Insider Sells $500,213.00 in Stock

Encompass Health Co. (AMEX:EHC) insider Elissa Joy Charbonneau sold 6,650 shares of the business’s stock in a transaction on Tuesday, November 17th. The stock was sold at an average price of $75.22, for a total value of $500,213.00. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Encompass Health Co. has a 52-week low of $40.86 and a 52-week high of $59.29.

Encompass Health (AMEX:EHC) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $0.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.03.

A number of equities research analysts recently weighed in on EHC shares. Raymond James reduced their price objective on Encompass Health from $86.00 to $78.00 and set an “outperform” rating on the stock in a research report on Monday, November 2nd. Deutsche Bank Aktiengesellschaft reduced their price objective on Encompass Health from $83.00 to $70.00 and set a “hold” rating on the stock in a research report on Friday, October 30th. Jefferies Financial Group reduced their price objective on Encompass Health from $90.00 to $86.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Finally, Credit Suisse Group reduced their price objective on Encompass Health from $89.00 to $85.00 and set an “outperform” rating on the stock in a research report on Monday, November 2nd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have given a buy rating to the stock. Encompass Health presently has an average rating of “Buy” and a consensus price target of $85.53.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: How Investors Use a Balance Sheet

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.